Adding PHS to the model that uses APOE burden led only to statistically significant improvement for the CN versus Alzheimer’s disease classification (AUC increased from 0.765 to 0.777; P < 0.006; Supplementary Table 2 and Fig. 2). This evidence concerns the gene APOE and Alzheimer disease.